Dual Implant Versus Single Implant Distal End of Femur
- Conditions
- Femur Fracture
- Interventions
- Procedure: Single Distal Femur ImplantProcedure: Dual Distal Femur Implant
- Registration Number
- NCT06032299
- Lead Sponsor
- Mayo Clinic
- Brief Summary
This research study is being conducted to examine the effect of two versus one fixation device for fixation of distal femur fractures.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
- Femur fracture distal to the femoral diaphysis.
- Operative treatment within 72 hours of presenting to the treating hospital.
- Patient was previously ambulatory.
- Fracture amendable to either single or dual implant fixation.
- Informed consent can be obtained from the patient, family member, or power of attorney.
- Associated major lower extremity fracture.
- Ongoing infection.
- History of metabolic bone disease (Paget's, etc).
- Pathologic fracture.
- Open fracture.
- Severe cognitive impairment (Six Item Screener with 3 or more errors).
- Stage 5 Parkinson's disease.
- Significant femoral bone loss requiring planned staged bone grafting.
- Vascular injury.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Single Distal Femur Implant Group Single Distal Femur Implant Subjects will receive one of two types of implants for the distal femur fracture. The single implant will be either a plate and screws or a rod. The type of single implant used will be determined by the surgeon based on the characteristics of the fracture. Dual Distal Femur Implant Group Dual Distal Femur Implant Subjects will receive two implants for fixation of the distal femur fracture. The dual implant will be either 2 plates with screws or a plate with screws and a rod. The type of dual implant used will be determined by the surgeon based on the characteristics of the fracture.
- Primary Outcome Measures
Name Time Method Number of study-eligible subjects Baseline Total number of subjects to be enrolled in the study
- Secondary Outcome Measures
Name Time Method Early post-surgical complications 2 weeks post-surgery Number of subjects to experience venous thromboembolism (VTE), cardiopulmonary, and/or infectious complications after surgery
Hospitalization days approximately 2-3 days Total number of days a subject requires hospitalization after surgery
Blood loss Duration of surgery, approximately 2-4 hours Total amount of surgical blood loss, reported in mL.
Operative times Duration of surgery, approximately 2-4 hours Total recorded amount of time in minutes to complete the surgery
Trial Locations
- Locations (1)
Mayo Clinic Minnesota
🇺🇸Rochester, Minnesota, United States